Sector Pharmaceuticals & Biotech. - Latest news, views and updates

SECTOR | 31 Aug 2025, 10:30AM

Repurposed drug statin found to slow cancer growth, boost treatment support

Business Standard

Statins, which help treat high cholesterol, have been found to slow down the growth of colorectal tumours, according to a new study, making researchers consider the possibility of repurposing the drug to support cancer treatment. However, more clinical trials are needed to provide scientific evidence before statins can become part of standard cancer treatment, they said. Drug repurposing, an alternative to the conventional way of developing medicines from scratch, accelerates the pace of discovery since existing medicines and compounds being used for it have already passed safety tests. Owing to a need to reduce the cost of developing drugs, the idea has gained traction in recent years with advances in computing power, artificial intelligence and bioinformatics helping in the identification of new uses for existing drugs more systematically and quickly. Cancer is among the multiple diseases, including rheumatoid arthritis and HIV/AIDS, for which drug repurposing is being...

Pharmaceuticals & Biotech.

SECTOR | 30 Aug 2025, 10:38PM

Medical Devices Demand To Surge If GST Rate Slashed, Says Poly Medicure MD

NDTV Profit

Poly Medicure MD expects domestic product volumes to rise as the healthcare sector grows 1215% yearly.

Pharmaceuticals & Biotech.

SECTOR | 24 Aug 2025

US aid cuts leave South Africa's most vulnerable struggling for HIV drugs

Business Standard

On a warm evening in Johannesburg, the news spread like wildfire among sex workers: Within 24 hours, several nonprofit clinics providing free HIV services would be closing as President Donald Trump announced the United States was slashing foreign aid. Some South Africans living with, or at risk of, HIV secured supplies of life-saving drugs just in time. Others did not. Half a year later, the country with more people living with HIV than any other is struggling to treat its most vulnerable. Over 63,000 people were being treated in the 12 clinics across the nation that shut down. Up to 220,000 people have faced disruption to their daily HIV medication. South Africa's government has vowed it won't let the US withdrawal of about USD 427 million in support collapse its HIV program, the largest in the world. Sex workers, among the most vulnerable South Africans as their work is illegal, and transgender people spoke to The Associated Press on condition of anonymity for fear of retaliation

Pharmaceuticals & Biotech.

SECTOR | 21 Aug 2025

Why men are more likely to die from diabetes, hypertension and HIV

Business Standard

A global study in PLOS Medicine shows men have higher death rates from diabetes, hypertension and HIV/AIDS, largely due to risky lifestyles and lower healthcare use

Pharmaceuticals & Biotech.

SECTOR | 20 Aug 2025

Rains Making You Spend More? Breaking Down Seasonal Expenses From Transport To Medicines

NDTV Profit

Right from miscellaneous spends like umbrellas to season specific spends like medicines, planners warn that these monsoon can put one in a tight spot if not properly accounted for.

Pharmaceuticals & Biotech.

SECTOR | 19 Aug 2025

Pharma sector faces tariff threats amid rising US trade actions: Report

Business Line

The US is a key market for Indian drugmakers, and any tariff imposition could ripple across the sector

Pharmaceuticals & Biotech.

SECTOR | 13 Aug 2025

Senores Pharma to buy two ANDAs from Teva, its third US transaction this year

Business Line

The recently-listed Senores Pharma signed an agreement to acquire the two US Food and Regulatory Administration-approved ANDAs, that have an opportunity of $38 million

Pharmaceuticals & Biotech.

SECTOR | 07 Aug 2025

Medical devices industry raises concerns over additional 25% US tariff

Business Standard

With US duties on Indian medical devices now at 50%, industry groups warn of trade instability, lost competitiveness, and adverse impact on American patients

Pharmaceuticals & Biotech.

SECTOR | 07 Aug 2025

Domestic-focused strategy key amid global tariff turmoil: Sunil Subramaniam

Economic Times

Market expert Sunil Subramaniam advises investors on navigating tariff uncertainties. He suggests assessing risk profiles and considering domestic sectors. Pharma and IT sectors have seen corrections. Focus on consumption, banking, and capital goods. Multicap funds are recommended. RBI's stable policy and India's insulated economy offer reassurance. Paint stocks are promising due to domestic orientation and softening crude prices.

Pharmaceuticals & Biotech.

SECTOR | 16 Jul 2025

Senate votes to move ahead with Trump's request for $9 bn in spending cuts

Business Standard

Senate Republicans on Tuesday advanced President Donald Trump's request to cancel some USD 9 billion in previously approved spending, overcoming concerns from some lawmakers about what the rescissions could mean for impoverished people around the globe and for public radio and television stations in their home states. The Senate vote was 50-50, with Vice President JD Vance breaking the tie. A final vote in the Senate could occur as early as Wednesday. The bill would then return to the House for another vote before it would go to Trump's desk for his signature before a Friday deadline. Republicans winnowed down the president's request by taking out his proposed USD 400 million cut to a programme known as PEPFAR. That change increased the prospects for the bill's passage. The politically popular programme is credited with saving millions of lives since its creation under then-President George W. Bush to combat HIV/AIDS. The president is also looking to claw back money for foreign aid